TIAA Trust National Association Has $23.21 Million Position in Danaher Co. (NYSE:DHR)

TIAA Trust National Association raised its holdings in shares of Danaher Co. (NYSE:DHR) by 28.3% in the 4th quarter, HoldingsChannel reports. The firm owned 101,121 shares of the conglomerate’s stock after buying an additional 22,326 shares during the period. TIAA Trust National Association’s holdings in Danaher were worth $23,212,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth about $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the fourth quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC bought a new position in shares of Danaher during the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC lifted its holdings in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on DHR shares. The Goldman Sachs Group upgraded Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective on the stock in a research report on Friday, March 21st. Guggenheim assumed coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a report on Friday, December 13th. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Five analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $278.24.

Danaher Trading Down 0.2 %

NYSE DHR opened at $212.36 on Wednesday. The company has a market cap of $151.78 billion, a price-to-earnings ratio of 40.22, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The business’s fifty day moving average is $216.41 and its 200 day moving average is $237.75.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the business earned $2.09 EPS. As a group, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio is presently 24.24%.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.